Replies to post #317421 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Market cap should equal $20 billion discounted at 50% rate for 1.5 years

or $11 billion, $136 share now.

50% discount rate is a high venture capital rate that reflects risk and time.

$20 billion is value of alz treatment.

1 year to complete test, 6 months to fast track approval

Which means AVXL is grossly undervalued at current price.


Market cap should equal that of SAVA, thus $50/share for AVXL